Nuvaxovid is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults
A 40 minute daily Yoga routine, incorporating select asanas and pranayama, along with standard lifestyle interventions, can reduce the risk of developing diabetes by approximately 40%
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
Subscribe To Our Newsletter & Stay Updated
